Analgesia effect of two adjuvants combined with Ropivacaine on femoral nerve block after arthroscopic surgery of the knee

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400081276

Enrollment

Unknown

Registered

2024-02-28

Start date

2024-02-20

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

femoral nerve block after arthroscopic surgery of the knee

Interventions

Dexmedetomidine group (E1 group):dexmedetomidine combined with ropivacaine for femoral nerve block

Dexamethasone group (E2 group):dexamethasone combined with ropivacaine for femoral nerve block

Control group (group C): the group on femoral nerve block with ropivacaine alone

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Patients aged 18-65 years;? ASA I~III; ? BMI18~29kg/m2;? Elective knee arthroscopic surgery.

Exclusion criteria

Exclusion criteria: ?refuse to perform a femoral nerve block;?bradycardia and conduction block;?coagulation dysfunction;?skin infection at the puncture site;?History of severe cardiopulmonary disease;? Patients with severe central or peripheral nervous system diseases;?History of severe liver and kidney diseases;? Long term chronic pain and related drug history;?The follow-up record of 48 hours after surgery was incomplete.

Design outcomes

Primary

Measure	Time frame
Static and dynamic VAS scores;	—

Countries

China

Contacts

Public ContactHongyu Wang

Beijing Friendship Hospital Affiliated to Capital Medical University

13940481065@163.com+86 156 4054 5359

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026